Health · Medical Research · 1 hr ago

Study finds immune and tumor differences in pancreatic cancer samples

Study finds immune and tumor differences in pancreatic cancer samples

Researchers at the University of Cincinnati Cancer Center found differences in pancreatic tumors between patient groups.

They compared tumor samples from Black patients with samples from non-African American patients using several kinds of biological data.

Black patients’ samples had more B cells, which can weaken the body’s immune response to cancer.

The team said these cells may help tumors hide from the body’s defenses, though more research is needed to confirm this.

Cancer cells also showed different molecular markers, including markers linked to drug resistance.

These differences could affect responses to targeted treatments such as RAS inhibitors.

The researchers hope further work will identify tumor subtypes and support more personalized treatment, but the findings do not yet change current care.

1 source

Related

What people are saying

Nina SteeleStudy lead and assistant professor at the University of Cincinnati College of Medicine
This may mean the B cells are helping the cancer cells hide in this patient population
via SciTechDaily
The markers upregulated in Black patients likely represent a type of cells typically associated with drug resistance, so this biological difference could play a role in outcomes.
via SciTechDaily
We’re headed toward forecasting, the ability to better predict what will happen to every patient in their journey before it happens.
via SciTechDaily